AptarGroup, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
July 28, 2022 at 05:00 pm EDT
Share
AptarGroup, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 844.54 million compared to USD 811.03 million a year ago. Net income was USD 63.63 million compared to USD 55.28 million a year ago. Basic earnings per share from continuing operations was USD 0.97 compared to USD 0.84 a year ago. Diluted earnings per share from continuing operations was USD 0.95 compared to USD 0.81 a year ago.
For the six months, sales was USD 1,689.48 million compared to USD 1,587.79 million a year ago. Net income was USD 126.05 million compared to USD 139.23 million a year ago. Basic earnings per share from continuing operations was USD 1.92 compared to USD 2.12 a year ago. Diluted earnings per share from continuing operations was USD 1.88 compared to USD 2.05 a year ago.
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
APTARGROUP, INC. 
